Takehiro Yamaguchi, Ayano Watanabe, Masako Tanaka, Masayuki Shiota, Mayuko Osada-Oka, Soichi Sano, . . . Yasukatsu Izumi. (2019). A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4. Elsevier.
Chicago Style (17th ed.) CitationTakehiro Yamaguchi, et al. A Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, Linagliptin, Attenuates Cardiac Dysfunction After Myocardial Infarction Independently of DPP-4. Elsevier, 2019.
MLA (9th ed.) CitationTakehiro Yamaguchi, et al. A Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, Linagliptin, Attenuates Cardiac Dysfunction After Myocardial Infarction Independently of DPP-4. Elsevier, 2019.
Warning: These citations may not always be 100% accurate.